Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Daley

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drug Testing and Analysis|February 29, 2024
The origin of 2,5-dimethoxy-4-methylamphetamine (DOM, STP)Keeper Trout, Paul F Daley
Drug Testing and Analysis|July 2, 2020
Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trialsNicholas V Cozzi, Paul F Daley
Bioorganic & Medicinal Chemistry Letters|January 8, 2016
Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptaminesNicholas V Cozzi, Paul F Daley
Drug Testing and Analysis|February 25, 2012
Analytical characterization of three trifluoromethyl-substituted methcathinone isomersSimon D Brandt, Paul F Daley, Nicholas V Cozzi
Analytical Chemistry|July 1, 2005
Intelligent signal processing for detection system optimizationChi Yung Fu, Loren I Petrich, Paul F Daley, et al.
Drug Testing and Analysis|January 31, 2012
Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptaminesSimon D Brandt, Ruchanok Tearavarich, Nicola Dempster, et al.
Ground Water|May 10, 2006
Interpreting velocities from heat-based flow sensors by numerical simulationGrace W Su, Barry M Freifeld, Curtis M Oldenburg, et al.
Neuropharmacology|March 3, 2018
Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogsLandon M Klein, Nicholas V Cozzi, Paul F Daley, et al.
Drug Testing and Analysis|October 1, 2011
Microwave-accelerated preparation and analytical characterization of 5-ethoxy-N,N-dialkyl-[α,α,β,β-H(4) ]- and [α,α,β,β-D(4) ]-tryptaminesRuchanok Tearavarich, Viwat Hahnvajanawong, Nicola Dempster, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 17, 2009
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporterNicholas V Cozzi, Anupama Gopalakrishnan, Lyndsey L Anderson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drug Testing and Analysis|February 29, 2024
The origin of 2,5-dimethoxy-4-methylamphetamine (DOM, STP)Keeper Trout, Paul F Daley
Drug Testing and Analysis|July 2, 2020
Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trialsNicholas V Cozzi, Paul F Daley
Bioorganic & Medicinal Chemistry Letters|January 8, 2016
Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptaminesNicholas V Cozzi, Paul F Daley
Drug Testing and Analysis|February 25, 2012
Analytical characterization of three trifluoromethyl-substituted methcathinone isomersSimon D Brandt, Paul F Daley, Nicholas V Cozzi
Analytical Chemistry|July 1, 2005
Intelligent signal processing for detection system optimizationChi Yung Fu, Loren I Petrich, Paul F Daley, et al.
Drug Testing and Analysis|January 31, 2012
Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptaminesSimon D Brandt, Ruchanok Tearavarich, Nicola Dempster, et al.
Ground Water|May 10, 2006
Interpreting velocities from heat-based flow sensors by numerical simulationGrace W Su, Barry M Freifeld, Curtis M Oldenburg, et al.
Neuropharmacology|March 3, 2018
Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogsLandon M Klein, Nicholas V Cozzi, Paul F Daley, et al.
Drug Testing and Analysis|October 1, 2011
Microwave-accelerated preparation and analytical characterization of 5-ethoxy-N,N-dialkyl-[α,α,β,β-H(4) ]- and [α,α,β,β-D(4) ]-tryptaminesRuchanok Tearavarich, Viwat Hahnvajanawong, Nicola Dempster, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 17, 2009
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporterNicholas V Cozzi, Anupama Gopalakrishnan, Lyndsey L Anderson, et al.
Pageof 2